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Background: Identification and tracking of important communicable diseases is pivotal to our understanding of
the geographical distribution of disease, the emergence and spread of novel and resistant infections, and are of
particular importance for public health policy planning. Moreover, understanding of current clinical practice norms
is essential to audit clinical care, identify areas of concern, and develop interventions to improve care quality.
However, there are several barriers to obtaining these research data. For example current disease surveillance
mechanisms make it difficult for the busy doctor to know which diseases to notify, to whom and how, and are also
time consuming. Consequently, many cases go un-notified. In addition assessments of current clinical practice are
typically limited to small retrospective audits in individual hospitals.
Therefore, we developed a free smartphone application to try to increase the identification of major infectious
diseases and other acute medical presentations and improve our understanding of clinical practice.
Description: Within the first month there were over 1000 downloads and over 600 specific disease notifications,
coming from a broad range of specialities, grades and from all across the globe, including some resource
poor settings.
Notifications have already provided important information, such as new cases of TB meningitis, resistant HIV and
rabies, and important clinical information, such as where patient with myocardial infarctions are and are not
receiving potentially life-saving therapy.
The database generated can also answer new, dynamic and targeted questions. When a new guideline is released,
for example for a new pandemic infection, we can track, in real-time, the global usage of the guideline and
whether the recommendations are being followed. In addition this allows identification of where cases with key
markers of severe disease are occurring. This is a potential resource for guideline-producing bodies, clinical
governance and public health institutions and also for patient recruitment into ongoing studies.
Conclusions: Further parallel studies are needed to assess the clinical and epidemiological utility of novel disease
surveillance applications, such as this, with direct comparisons made to data collected through routine surveillance routes.
Nevertheless, current disease surveillance mechanisms do not always comprehensively and accurately reflect disease
distribution for many conditions. Smartphone applications, such as ClickClinica, are a novel approach with the potential
to generate real-time disease surveillance data that may augment current methods.
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Improved understanding of the development and distribu-
tion of novel and resistant infections requires robust and
readily utilised identification and tracking mechanisms.
This is fundamental for adequate public health policy
planning [1]. In addition, a clear understanding of current
clinical practice norms is necessary to audit clinical care,
identify areas of concern and develop interventions to
improve care quality [2].
Whilst many countries have national disease surveil-
lance programmes for major communicable diseases, or
‘notifiable diseases’, the work of our group and others
has identified several areas of sub-optimal notification,
even in the developed countries. For example, it is
estimated by the Health Protection Agency (HPA), that
for each laboratory confirmed cases of the major
gastrointestinal infection, norovirus, there are up to a
further 288 unreported cases [3]. Furthermore, a UK-wide
prospective longitudinal study found that, for gastrointes-
tinal infection overall, for every one case notified to
national surveillance, there were 10 GP consultations and
147 community cases [4].
With regards to the major neurological infection, there
were only 18 cases of acute encephalitis notified to the
HPA in 2007 [5]. However, during a 3 month study
conducted in the same year in only 10 adult hospitals we
identified 13 cases of encephalitis [6]. In addition, the
notification of acute viral meningitis between 2004–2006
was approximately 1381 per year [5]. During this same
period in a single 950 bed general non-specialist NHS
teaching hospital, we identified 68 hospitalised patients
with viral meningitis [7]. If extrapolated across the 159,386
NHS beds over this same time period, the estimated
number of cases would be nearly three times larger
(n = 3,802 cases). [8] Indeed several studies have reported
that the true incidence of meningitis in the UK may be
10–14 times higher than notified figures [9-11].
Nevertheless, microbiological notification of specific
organisms which have been identified maybe somewhat
better, as there are clear notification standard operating
procedures in most laboratories. However, this may
falsely skew epidemiological data to favour particular
organisms of interest. For example, in 2011, 263 (48.8%)
of all acute meningitis notifications to the HPA were due
to Neisseria meningitidis [5]. Whereas, in disease-specific,
rather than organism-specific, surveillance programmes
in developed countries only around 13% of all meningi-
tis cases are due to Neisseria meningitidis [12]. Further-
more, overall bacteria may only account for up to 26% of
meningitis [13].
The Centre for Disease Control and Prevention (CDC)
has brought together several reporting systems, including
for HIV and TB, into a single place through the National
Electronic Disease Surveillance System (NEDSS) [14].However, this approach still requires each individual to
upload their data and does not collect data automatically
from doctors on the front line of patient care.
Suboptimal notification from doctors on the front line
may potentially be due to lack of awareness that the
condition is a notifiable one, lack of knowledge of the
procedure for notification and/or limited resources to
facilitate the notification process, such as limited time.
From previous work we have found that simple inter-
ventions, such as providing the appropriate bottle for
virus identification or for cancer cell identification within
the kits doctors use when performing a lumbar puncture,
we could increase the identification of viruses and cancer
cells [15,16]. Although most doctors knew the importance
of sending these types of sample, making it less time-
consuming to collect them resulted in real changes in
practice and disease identification.
In addition assessments of current clinical practice are
typically limited to small retrospective audits of case notes
in individual hospitals. Therefore, they only provide
delayed information, which is specific to a locality rather
than reflecting wider healthcare practice [17].
To start to address some of these issues and to enhance
disease surveillance, novel technological approaches, such
as ‘crowdsourcing’ are being increasingly used. For example,
two recent papers report attempts to use Google © trends
data to assess influenza incidence and compared this with
CDC data. One identified good correlation between Google
© influenza search trends and CDC notifications and one
utilised these data to develop a mathematical model to pre-
dict influenza outbreaks 7 weeks prior to the occurrence.
[18,19] However, whilst this approach utilises large datasets,
which are required to generate such models, the veracity of
the data is less robust than that submitted by clinicians.
Medical technology, such as ‘Apps’ for smartphones
are revolutionising the way doctors practice medicine,
increasing dissemination of research and making clinical
guidelines more widely available [20]. However, the majority
of these support only unidirectional traffic of information
(e.g. simply dissemination of guidelines or monitoring of
an individual’s health parameters, such as blood pressure
recordings, and relaying this information to their individual
doctor) [21]. A structured Medline search was conducted
for papers between 1985-current in any language using the
search terms: “smartphone” OR “phone” OR “application”
WITH “disease surveillance” OR “epidemiology”. A further
search was conducted using the above search terms in the
Apple App Store ©. However, neither approach identified
any applications, which allow for the bidirectional flow
of data from a central database to clinicians (i.e. clinical
guidelines) and from clinicians to a central database
(i.e. disease notifications).
Therefore, we set out to develop a novel smartphone
application with bidirectional information traffic to try
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surveillance though increasing the notification of major
infectious and other acute diseases and secondly to
improve our understanding of current clinical practice
(https://sites.google.com/site/clickclinicarx/).
Construction and content
The application brings together the clinical guidelines
from across guidelines groups in a single place and is
made freely available for the iPhone. These include
guidelines from large national and international bodies
such as the National Institute for Health and Clinical
Excellence (NICE), HPA, CDC, the Resuscitation Council,
the World Health Organization (WHO) and many others,
Depending on the size of each guideline, they are either
stored in whole or as a clinical summary of the key points
as a PDF. Therefore, the clinician does not require inter-
net access at the time they wish to get the information.
Where guidelines were given in summary format or further
multimedia material is available, a hyperlink to the full
online guideline is provided. In a similar way to our previous
projects, in which we have found that interventions that
reduce the time required from doctors have the greatest
impact, the app does not require any additional effort
from the doctor than simply reading the guidelines they
want to read anyway [15,16]. Indeed, by making them
readily available and clearly indexed, it is easier for the
doctor to use the app to read a section of the guidelines
than it is to perform an internet search, then find the
website, then find the document, then download the PDF,
then scroll through to find the page of interest.
In reading guidelines on the application, the app has
the potential to generate a real-time global disease
surveillance database based on the usage. Also from a
brief question that appears on the bottom of the screen
when viewing a specific disease, more detailed information
on either important epidemiological or clinical care
quality issues can be collected. One example is that
when a doctor is viewing a guideline on H1N1 influenza,
our central database is made aware that the guideline is
being read and the doctor’s grade and hospital. Moreover,
on clicking yes in the ‘question box’ at the bottom of the
screen, such as “Are you prescribing chemoprophylaxis?”
we are immediately also notified that the doctor has
answered the question and their name, specialty, GPS
location and, if allowed, email address, medical registration
number and also whether the doctor is happy to be
contacted for research purposes regarding this case. In
answering the question this ‘question box’ disappears
providing more space for the guideline to be viewed
(Figure 1). The doctor only needs to input their personal
information once at the point of downloading the applica-
tion (Figure 2). Therefore, the application allows us to
immediately track the distribution of disease, the spreadof outbreaks and their management. The question at
the bottom of the screen is specific for each disease, or
sub-section within the disease guideline.
For example, for influenza:
 When reviewing the front page, the question is “are
you seeing a patient with H1N1?”
 When reviewing the resistance page within the
influenza document the question is “does this
patient have resistant virus?”
 When reviewing the treatment table within the
influenza document the question is “are you
prescribing antivirals?”
Whilst these questions are currently set centrally by
the ClickClinica team, as the project expands we are
collaborating with other research institutions to use our
platform for them to include research questions of interest
to their particular field. The data collected regarding this
is made freely available to them to access in real-time
through a dedicated terminal, including questions submitted
by users. When the app is used in a situation where a
clinician does not have an internet connection (be that
Wi-Fi or wired internet) the notification is stored within
the application and subsequently submitted to the central
database automatically when an internet connection is
established.
By obtaining comprehensive data on the usage of the
app, we are able to include guidelines that reflect usage
in future updates. In addition the application contains a
‘Flag it up’ button, which allows users to suggest guidelines
they would like to see in future updates of the application.
To encourage use of the application, we have included
guidelines to all the major acute medical presentations
that are covered in competing paid-for applications and
handbooks. Also, we have made it possible for clinicians
to print, email or bookmark the guidelines directly from
their smartphone. This also helps to foster guideline
dissemination and the creation of a personalised app. To
encourage users to answer the research questions we
have included internal ClickClinica © certificates that
can be used as evidence of involvement in research for
their portfolio of continuing professional development.
Also at any time the user can view their personalised
index of recorded cases.
Utility and discussion
The database generated from the usage of the app can
also answer new, dynamic and targeted questions. When
a new guideline is released (e.g. for a new pandemic
infection) this app has the potential to track, in real-time,
the global uptake and usage of the guideline. We can also
assess whether the recommendations in that guideline
(e.g. vaccine delivery) are being followed and where
Figure 1 Guideline and database views, with questions being answered.
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Figure 2 Launching the ClickClinica© application and initial registration.
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logical involvement) are occurring. This is a potential
resource of clinical information not only for guideline-
producing bodies but also for clinical governance and
public health institutions.
At the time of writing, the app has only been live for
just over 4 weeks and has already received over 1000
downloads and over 600 specific disease notifications.
The app did not receive any external funding and did
not undergo a marketing campaign. Potential users were
made aware of the app through the Apple App Store,
within the ‘free medical applications’ category. In an
effort to reduce spurious notifications, the app was
designed such that it is equally efficient for the userremove the ‘question box’ from the screen by choosing
to not notify as it is if they notify. Of the notifications,
578 (96%) have included an email address and 405 (70%)
of these notifications have included consent to be
contacted to provide further information for research
purposes on the case they have notified.
Data quality is assessed firstly by the veracity of the
user’s details (e.g. the data is treated as the weakest
possible evidence of a disease notification when the report
only contains the user’s name). The data is treated as most
robust when a notification contains the user’s name,
official NHS email address and General Medical Council
number, which are crosschecked with the database.
Furthermore, downstream data quality assessment is
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multiple disease notifications during a short period of time
(e.g. if the same disease is notified repeatedly within
10 minutes or multiple diseases are notified within
5 minutes) as such situations are likely to reflect users
simply reading the guidelines for their interest or initially
to ‘test out’ the app, rather than in relation to a specific
patient. Nevertheless, we have endeavored to minimise
these types of inappropriate notifications, as it is equally
efficient, from a user’s point of view, to not notify, as it is
to notify.
Specific disease notifications have come from a broad
range of clinical specialities, including General Practice
(25%), Emergency Medicine (15%), General Medicine
(14%), and Anaesthetics, Paediatrics, Surgery, Infectious
Diseases, Psychiatry, Cardiology, and Neurology.
Also, downloads and notifications have been coming
from across the globe, including some resource-poor
countries (Figure 3), and from a wide range of grades,
including Foundation Doctors (24%), Medical Trainees
(21%), Specialist Registrars (23%), Consultants (18%),
and Professors/Lecturers (6%).
Our data collection approach allows us to collect both
the denominator data (i.e. which guidelines are being
read by whom) and the numerator data (i.e. specific
disease notifications). Therefore, we are able to monitor
usage of the app generally as well as usage of the app for
disease notifications. This allows us to assess data collected
as both simple frequencies and also as a proportion of
usage for that individual user and also as a proportion
of usage of the specific disease guideline of interest.
Furthermore, these data can be visualised as a global orFigure 3 Real-time global disease database generation; Live 10.23 amregional heat-map which can incorporate population
data, for example disease notifications can be represented
as an incidence within a population or even and incidence
within a population exposed to a particular environmental
risk factor. Notifications have already provided really im-
portant clinical information, for both disease surveillance
and for clinical care quality assessment. Some examples of
data collected are described in the table (Table 1).
The application does not collect any patient-identifiable
demographic data, but rather the data is of the doctor's
practice, which they have agreed to provide at the point of
installing the app. In addition, it also has the potential to
increase recruitment into ongoing clinical studies. If a
doctor is seeing a patient and reading a guideline for a
disease in a hospital in which there is an ongoing study,
then an automated system can generate an email to the
doctor and the research nurse for that hospital allowing
them to make contact to consent the patient to be recruited
into that study (Figure 4). Therefore, no confidential or
patient-identifiable information is made available centrally.
During this initial proof-of-concept pilot phase of the
application, notifications from the individual user are
available for them to review for themselves within the
app itself. However, the wider database was only avail-
able to the central research team. Nevertheless, as
there has been growing interest in the potential for this
rich data source to inform future research, we have
developed a number of research collaborations, including
with researchers at the universities of Liverpool, San
Diego and Oxford, through whom we are making the
data relating to the conditions of interest readily
accessible., 5th November 2012.
Table 1 Examples of data collected for disease surveillance and clinical care quality assessment
Notification type Example(s)
Disease Surveillance Three new cases of TB meningitis: one in the UK and two in Pakistan
Diagnosis of rabies in Myanmar
Clinical care quality Of 48 patients with an ST-elevation myocardial infarction; seven received intravenous nitrates;
only two received thrombolysis
Of 21 patients with exacerbations of chronic obstructive pulmonary disease; five required
non-invasive ventilation; only two were able to be managed in the community
Of the eight patients with dementia, only three were prescribed an anticholinergic
Of five patients with HIV, one required 2nd line therapy for drug-resistant disease
Assessing dissemination and education 23 doctors assessed a patient with suspected meningitis, decided whether to perform a
lumbar puncture and then watched the video on how to do it
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doctors using clinical guidelines. This will vary between
disease areas in response to many factors, such as
disease complexity or rarity, new guideline availability,
individual clinician experience with the disease in question
and available time. In addition, doctors do not typicallyFigure 4 Schematic demonstrating data transfer of content and reporefer to guidelines for every patient they see, particularly
in areas where they are able to practice without seeking
further information, and in these areas our data collection
will be more limited. Nevertheless, clinicians regularly use
guidelines and other reference texts to access information
that is difficult to remember, such as drug dosages, whichrts between users, researchers and the central team.
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diseases that are not routinely seen. Furthermore, routine
use of clinical guidelines, and indeed audit of their use,
has an increasingly important role in day-to-day clinical
practice. Moreover, as it does not require any additional
time to notify a disease once they are reading the guideline,
it is hoped that, if even only for specific disease areas,
some useful data will be collected. Nevertheless, as novel
technologies start to generate a new type of epidemio-
logical data, new approaches to understanding and auto-
mating how best to interpret these data, including
algorithm generation, will be required [22,23].
Future versions of the application will need to be
developed for other smartphone platforms, such as the
Google Android© market. As many doctors use smart
phones on a daily basis there is at least the potential to
access a wide cohort from whom to collect data. Moreover,
future iterations could provide information for, and access
data from, allied health care professionals, scientists and
the wider public.
Conclusions
It is unclear at this very early stage if this sort of
approach can improve disease surveillance and clinical
practice research, or indeed how many doctors would
have to use such an app to create the critical mass to
collected meaningful data. Further studies are needed to
assess the data collected through these approaches in
parallel with that collected through ongoing studies and
routine surveillance approaches.
Nevertheless, current approaches appear to miss many
cases and novel approaches, such as ClickClinica ©, may
provide data to start to address this.
Availability and requirements
The ClickClinica© database is held centrally and password
encrypted. However, research, guideline-development and
care quality groups can apply to access data for specific
guidelines and diseases, and can also apply to include
research questions or guidelines of interest to them in
future ClickClinica © application updates.
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